Journal article icon

Journal article

Navigating the Hepatic Immune Landscape With Fine Needle Aspiration of the Liver—An Emerging Technique

Abstract:
Background and Aims: Hepatic immune cell analysis is critical for understanding chronic inflammatory liver diseases, such as primary sclerosing cholangitis (PSC) and steatotic liver disease. However, liver immunoprofiling is limited due to reliance on end‐stage disease liver explants. Fine needle aspiration (FNA) is a minimally invasive technique that can overcome these limitations. We evaluate the safety and efficacy of liver FNA to profile hepatic immune subsets in non‐infectious liver conditions. Methods: Flow cytometry and single‐cell RNA sequencing (scRNA‐seq) were used to compare the hepatic immune cell composition and gene expression to that of matched peripheral blood mononuclear cells (PBMCs). Results: We obtained liver FNAs from 38 patients. The median pain score was 0. No serious adverse effects were reported. Flow cytometry demonstrated enrichment of CD69+ T and natural killer (NK) cells in the liver (all P adj < 0.05). ScRNA‐seq of 38 012 hepatic immune cells and 78 751 PBMCs in a patient subset showed specific enrichment of CXCR6+ NK, CD8+ central memory T, and mucosal‐associated invariant T (MAIT) cells in the liver, and relatively lower CD4+ regulatory T cell (Treg) abundance (all P adj < 0.05). Gene expression and cell–cell interaction analyses revealed increases in cytokine production, signalling, and responsiveness in hepatic immune cells compared to PBMCs. Conclusions: FNA sampling is a safe approach for investigating the inflammatory landscape of PSC and other liver diseases. Single‐cell profiling reveals that FNAs capture tissue‐specific immune cell types and gene expression differences, suggesting this sampling method may provide a basis for future experimental medicine analyses.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/liv.70358

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7748-2165
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
https://ror.org/029chgv08


Publisher:
Wiley
Journal:
Liver International More from this journal
Volume:
45
Issue:
11
Article number:
e70358
Publication date:
2025-10-21
Acceptance date:
2025-09-09
DOI:
EISSN:
1478-3231
ISSN:
1478-3223


Language:
English
Keywords:
Pubs id:
2307570
Local pid:
pubs:2307570
Source identifiers:
3392981
Deposit date:
2025-10-21
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP